[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SK8495A3 - Chiral 1-imidazoletanol derivatives, method of their production and intermediates on their production - Google Patents

Chiral 1-imidazoletanol derivatives, method of their production and intermediates on their production Download PDF

Info

Publication number
SK8495A3
SK8495A3 SK84-95A SK8495A SK8495A3 SK 8495 A3 SK8495 A3 SK 8495A3 SK 8495 A SK8495 A SK 8495A SK 8495 A3 SK8495 A3 SK 8495A3
Authority
SK
Slovakia
Prior art keywords
chiral
formula
nitro
imidazole
hydroxy
Prior art date
Application number
SK84-95A
Other languages
English (en)
Slovak (sk)
Inventor
Gerald Adams
Edward M Fielden
Matthew Naylor
Ian J Stratford
Vladimir G Beylin
Anthony D Sorcel
Howard D H Showalter
Original Assignee
Warner Lambert Co
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, British Tech Group filed Critical Warner Lambert Co
Publication of SK8495A3 publication Critical patent/SK8495A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK84-95A 1992-07-31 1993-07-26 Chiral 1-imidazoletanol derivatives, method of their production and intermediates on their production SK8495A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92320992A 1992-07-31 1992-07-31
PCT/US1993/006973 WO1994015922A1 (en) 1992-07-31 1993-07-26 Novel process for preparing chiral [[(2-bromoethyl)amino]methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds

Publications (1)

Publication Number Publication Date
SK8495A3 true SK8495A3 (en) 1995-08-09

Family

ID=25448313

Family Applications (1)

Application Number Title Priority Date Filing Date
SK84-95A SK8495A3 (en) 1992-07-31 1993-07-26 Chiral 1-imidazoletanol derivatives, method of their production and intermediates on their production

Country Status (12)

Country Link
US (4) US5342959A (es)
EP (1) EP0652870A1 (es)
JP (1) JPH07509489A (es)
KR (1) KR950702537A (es)
AU (1) AU4784293A (es)
CA (1) CA2136328A1 (es)
CZ (1) CZ10395A3 (es)
FI (1) FI950383A (es)
HU (1) HUT71347A (es)
MX (1) MX9304399A (es)
SK (1) SK8495A3 (es)
WO (1) WO1994015922A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5965621A (en) * 1995-08-17 1999-10-12 Allergan Methods and compositions for reducing or maintaining body weight in a mammal
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1590440A4 (en) * 2003-02-03 2009-03-18 Palo Alto Inst Of Molecular Me CELL-KILLING MOLECULES AND METHODS FOR THEIR USE
CN1314396C (zh) * 2005-04-28 2007-05-09 南京圣和药业有限公司 左旋奥硝唑在制备抗厌氧菌感染药物的应用
CN1332662C (zh) * 2005-04-29 2007-08-22 南京圣和药业有限公司 左旋奥硝唑的静脉给药制剂及其制备方法
CN1305469C (zh) * 2005-07-08 2007-03-21 南京圣和药业有限公司 左旋奥硝唑在制备抗寄生虫感染的药物中的应用
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
CN100368402C (zh) * 2005-11-16 2008-02-13 沈阳中海生物技术开发有限公司 奥硝唑光学对映体的制备方法
CN112774569B (zh) * 2021-01-11 2022-04-08 江门市华熊新材料有限公司 含氟咪唑表面活性剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
GB2123816B (en) * 1982-05-27 1986-03-19 Nat Res Dev Nitrolmidazole derivatives
US4946496A (en) * 1982-06-01 1990-08-07 E. I. Du Pont De Nemours And Company Herbicidal diazoles
ES2080726T3 (es) * 1987-12-04 1996-02-16 British Tech Group Compuestos aromaticos o heteroaromaticos nitrosustituidos para su utilizacion en el tratamiento del cancer.
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.

Also Published As

Publication number Publication date
CA2136328A1 (en) 1994-07-21
AU4784293A (en) 1994-08-15
US5481000A (en) 1996-01-02
EP0652870A1 (en) 1995-05-17
JPH07509489A (ja) 1995-10-19
CZ10395A3 (en) 1995-11-15
MX9304399A (es) 1994-02-28
HU9500269D0 (en) 1995-03-28
US5543527A (en) 1996-08-06
FI950383A0 (fi) 1995-01-27
HUT71347A (en) 1995-11-28
KR950702537A (ko) 1995-07-29
US5342959A (en) 1994-08-30
FI950383A (fi) 1995-01-27
US5659048A (en) 1997-08-19
WO1994015922A1 (en) 1994-07-21

Similar Documents

Publication Publication Date Title
SK8495A3 (en) Chiral 1-imidazoletanol derivatives, method of their production and intermediates on their production
CN1046278C (zh) 吡咯胺衍生物
CN1091596C (zh) 抗真菌剂及其化合物和它们的制备方法
JPH09507241A (ja) 新規な置換されていてもよいフェニルイミダゾリジン類、それらの製造法及び中間体、それらの薬剤としての用途並びにそれらを含有する製薬組成物
US20120189623A1 (en) Cyclized derivatives as eg-5 inhibitors
US10654876B2 (en) TH-302 solid forms and methods related thereto
US4581368A (en) Aziridino containing nitro imidazoles and pharmaceutical compositions
EA017748B1 (ru) Замещённые триазолы в качестве ингибиторов кбв
CN101557810B (zh) 作为痕量胺相关受体（taar）的配体的新的2-咪唑类
JP2024020453A (ja) Ｒｏｃｋ阻害剤としての重水素化合物
CA2003868A1 (en) Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
US7323433B2 (en) R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole
US12187686B2 (en) BRD4-JAK2 inhibitors
DE69813886T2 (de) Naphthalin derivate
US4282230A (en) Imidazolylethoxy derivatives of quinoline-2- or 4-methanols, antimicrobial compositions containing them and method for treating bacterial or fungal infections with them
JPH02223560A (ja) イミダゾリン誘導体を含有する宿主動物の外部寄生虫の浸透性防除剤および新規なイミダゾリン誘導体
US4234589A (en) Imidazolylethoxymethyl derivatives of 1,3-dioxolo quinolines
FR2582835A1 (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant
RU2126801C1 (ru) Алкильные производные тразодона, способ их получения, промежуточные соединения и фармацевтическая композиция
CN1112113A (zh) 新的三唑化合物及其制备方法和用途
EP0030371A1 (en) N-substituted imidazole derivatives, a process for their preparation, antifungal compositions comprising them and their use for preparing such compositions
AU603380B2 (en) Compounds useful in the synthesis of 1-aziridinoalkyl nitroimidazoles
US4997833A (en) Aryloxy-aminoalkanes, and antihypertensive use thereof
US4191831A (en) Imidazolylethoxy derivatives of pyridin-5-methanols
US4260616A (en) Antimicrobial imidazolylethoxymethyl derivatives of 1,3-dioxolo quinolines